Opinion/decision on a Paediatric investigation plan (PIP): Evusheld, tixagevimab,cilgavimab, decision type: P: decision agreeing ...
Invented name Evusheld Active Substance Therapeutic area Infectious diseases Decision number P/0119/2023 PIP number EMEA-003079-PIP01-22 Pharmaceutical form(s) Solution for injection Condition(s) / indication(s) Prevention of Coronavirus disease 2019 ( …